Biomarkers for Alzheimer’s disease beyond amyloid and tau

被引：0
|
作者：
Henrik Zetterberg
Jonathan M. Schott
机构：
[1] Sahlgrenska Academy at the University of Gothenburg,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology
[2] Sahlgrenska University Hospital,Clinical Neurochemistry Laboratory
[3] Department of Neurodegenerative Disease,undefined
[4] UCL Queen Square Institute of Neurology,undefined
[5] UK Dementia Research Institute at UCL,undefined
[6] Dementia Research Centre,undefined
[7] Box 16,undefined
[8] National Hospital for Neurology and Neurosurgery,undefined
来源：
Nature Medicine | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Two new biomarkers for Alzheimer’s disease include one in the blood that relates to neurodegeneration and another that reflects blood–brain barrier dysfunction and is identifiable in cerebrospinal fluid analysis.
引用
收藏
页码：201 / 203
页数：2
相关论文
共 50 条
  • [1] Biomarkers for Alzheimer's disease beyond amyloid and tau
    Zetterberg, Henrik
    Schott, Jonathan M.
    NATURE MEDICINE, 2019, 25 (02) : 201 - 203
  • [2] CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease
    Rosenmann, Hanna
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 47 (01) : 1 - 14
  • [3] CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease
    Hanna Rosenmann
    Journal of Molecular Neuroscience, 2012, 47 : 1 - 14
  • [4] Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
    Jinny Claire Lee
    Soo Jung Kim
    Seungpyo Hong
    YoungSoo Kim
    Experimental & Molecular Medicine, 2019, 51 : 1 - 10
  • [5] Tau and amyloid β protein in cerebrospinal fluid as biomarkers of Alzheimer's disease
    Kanai, M
    Harigaya, Y
    Kawarabayashi, T
    Ikeda, M
    Okamoto, K
    Shoji, M
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S380 - S380
  • [6] Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers
    Lee, Jinny Claire
    Kim, Soo Jung
    Hong, Seungpyo
    Kim, YoungSoo
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 51 (5): : 1 - 10
  • [7] Amyloid-beta and tau protein beyond Alzheimer's disease
    Morteza Abyadeh
    Vivek Gupta
    Joao A.Paulo
    Arezoo Gohari Mahmoudabad
    Sina Shadfar
    Shahab Mirshahvaladi
    Veer Gupta
    Christine T.O.Nguyen
    David I.Finkelstein
    Yuyi You
    Paul A.Haynes
    Ghasem H.Salekdeh
    Stuart L.Graham
    Mehdi Mirzaei
    Neural Regeneration Research, 2024, (06) : 1262 - 1276
  • [8] Amyloid-beta and tau protein beyond Alzheimer's disease
    Abyadeh, Morteza
    Gupta, Vivek
    Paulo, Joao A.
    Mahmoudabad, Arezoo Gohari
    Shadfar, Sina
    Mirshahvaladi, Shahab
    Gupta, Veer
    Nguyen, Christine T. O.
    Finkelstein, David I.
    You, Yuyi
    Haynes, Paul A.
    Salekdeh, Ghasem H.
    Graham, Stuart L.
    Mirzaei, Mehdi
    NEURAL REGENERATION RESEARCH, 2024, 19 (06) : 1262 - 1276
  • [9] Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
    Prvulovic, David
    Hampel, Harald
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (03) : 367 - 374
  • [10] Cognitive variation reflects amyloid, tau, and neurodegenerative biomarkers in Alzheimer's disease
    Phang, Kia Ann Sean
    Tan, Chin Hong
    GEROSCIENCE, 2025,
12345